# Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

> **NCT02663193** · — · COMPLETED · sponsor: **Janssen Scientific Affairs, LLC** · enrollment: 108 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT02663193
- **Lead sponsor:** Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02663193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02663193, "Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02663193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*